- Home
- LZB vs OPK Comparison
LZB vs OPK Comparison
Compare LZB & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LZB
- OPK
- Stock Information
- Founded
- LZB 1927
- OPK 2007
- Country
- LZB United States
- OPK United States
- Employees
- LZB N/A
- OPK N/A
- Industry
- LZB Home Furnishings
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- LZB Consumer Discretionary
- OPK Health Care
- Exchange
- LZB Nasdaq
- OPK Nasdaq
- Market Cap
- LZB 1.6B
- OPK 1.3B
- IPO Year
- LZB N/A
- OPK 1995
- Fundamental
- Price
- LZB $40.21
- OPK $1.65
- Analyst Decision
- LZB Hold
- OPK Strong Buy
- Analyst Count
- LZB 1
- OPK 3
- Target Price
- LZB N/A
- OPK $2.75
- AVG Volume (30 Days)
- LZB 726.8K
- OPK 3.9M
- Earning Date
- LZB 02-18-2025
- OPK 05-06-2025
- Dividend Yield
- LZB 2.19%
- OPK N/A
- EPS Growth
- LZB 7.87
- OPK N/A
- EPS
- LZB 2.91
- OPK N/A
- Revenue
- LZB $2,091,871,000.00
- OPK $713,142,000.00
- Revenue This Year
- LZB $3.42
- OPK N/A
- Revenue Next Year
- LZB $3.54
- OPK $8.11
- P/E Ratio
- LZB $13.79
- OPK N/A
- Revenue Growth
- LZB 1.80
- OPK N/A
- 52 Week Low
- LZB $32.00
- OPK $1.15
- 52 Week High
- LZB $48.31
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- LZB 47.46
- OPK 39.73
- Support Level
- LZB $37.96
- OPK $1.75
- Resistance Level
- LZB $40.46
- OPK $1.80
- Average True Range (ATR)
- LZB 1.19
- OPK 0.06
- MACD
- LZB 0.28
- OPK -0.03
- Stochastic Oscillator
- LZB 91.17
- OPK 18.52
About LZB La-Z-Boy Incorporated
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; and Retail, which sells upholstered and case goods furniture to the end consumer. The majority of the company's revenue is derived from its Wholesale segment.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.